ATLANTA, January 26, 2023--Alzamend Neuro to Present at Sequire Biotechnology Conference on Thursday, February 2, 2023; Highlighting Alzamend’s Achievements This Past Year
ATLANTA, January 04, 2023--Alzamend Neuro Partners With Biorasi to Conduct First-in-Human, Randomized, Double-Blind Placebo-Controlled Parallel Group Phase I/IIA Clinical Trial
ATLANTA, December 28, 2022--Alzamend Neuro Partners with Miller School of Medicine at the University of Miami for ALZN002 Phase I/IIA Immunotherapy Vaccine Clinical Trial for AD